A phase II study of combination therapy of a protracted oral schedule of temozolomide and thalidomide as first-line or subsequent therapy for patients with metastatic, locally advanced or unresectable leiomyosarcoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Temozolomide; Thalidomide
- Indications Leiomyosarcoma
- Focus Therapeutic Use
- 06 Jan 2014 Biomarkers information updated
- 05 Dec 2007 New trial record.